Modernizing Medicine to Host Must-Attend Event on COVID-19 Vaccine Timeline and Contact Tracing with Special Guest Jerome Kim, MD

Modernizing Medicine®, a leading healthcare technology company, is hosting a new installment in its thought leadership webinar series. The session, “World War C: Contact Tracing and the Hunt for a Vaccine,” will take place virtually on Tuesday, July 14 at 7 PM EDT. Those interested can register here.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200710005076/en/

Jerome Kim, MD, will be the special guest during Modernizing Medicine’s webinar, “World War C: Contact Tracing and the Hunt for a Vaccine,” on July 14 at 7 PM EDT. (Photo: Business Wire)

Modernizing Medicine’s Chief Medical and Strategy Officer and co-founder, Michael Sherling, MD, MBA, will speak with special guest, Jerome Kim, MD, director general of the International Vaccine Institute (IVI), about the latest pandemic news. With so many unknown variables and uncertainty, Dr. Kim will help shed light on the COVID-19 vaccination development timeline as well as how contact tracing plays a significant role in helping to combat this global pandemic.

Dr. Kim is an international expert on the evaluation and development of vaccines. He is a recognized leader in HIV vaccine development and was named one of the “50 Most Influential People in Vaccines” in 2014 by Vaccine Nation.

Dr. Kim stated that: “The novel coronavirus has had unprecedented impact on our lives, economy and our expectations. Accelerating vaccine development is one of those necessary adjustments. While a vaccine typically takes 5-10 years to develop, it’s now ‘all hands on deck’ to release a COVID-19 vaccine that prevents infection and/or disease as quickly, safely and fairly as possible.”

During this virtual event, Dr. Kim will share his expertise on the fight against COVID-19, including:

• What tools and strategies can be used to win ‘World War C’
• What effective contact tracing looks like in South Korea
• Updates on vaccine testing
• Which vaccine strategy could be more effective
• Signs that a vaccine is working

Dr. Michael Sherling shared that: “As physicians and healthcare professionals, we are all doing our best to treat patients in an uncertain world. I look forward to speaking with Dr. Kim and helping to provide a platform to share his invaluable knowledge with others in the healthcare community.”

As we continue to navigate the uncertainty of the COVID-19 pandemic, it’s important to rely on the power of information. To register for this event, click here.

About Modernizing Medicine

Modernizing Medicine® and its affiliated companies empower physicians with suites of mobile, specialty-specific solutions that transform how healthcare information is created, consumed and utilized to increase practice efficiency and improve patient outcomes. Built for value-based healthcare, Modernizing Medicine’s data-driven, touch- and cloud-based products and services are programmed by a team that includes practicing physicians to meet the unique needs of dermatology, gastroenterology, ophthalmology, orthopedics, otolaryngology, pain management, plastic surgery and urology practices, as well as ambulatory surgery centers. For more information, please visit www.modmed.com. Connect with Modernizing Medicine on our Blog, Facebook, LinkedIn and Twitter.

About the International Vaccine Institute (IVI)

The International Vaccine Institute (IVI) is a nonprofit inter-governmental organization established in 1997 at the initiative of the United Nations Development Programme (UNDP). Headquartered in Seoul, South Korea, IVI was the first international organization hosted by Korea. IVI has 35 signatory countries and the World Health Organization (WHO) on its treaty, including Korea, Sweden and India as state funders.

Our mandate is to make vaccines available and accessible for the world’s most vulnerable people. We focus on infectious diseases of global health importance such as cholera, typhoid, shigella, salmonella, schistosomiasis, Group A Strep, Hepatitis A, HPV, TB, HIV, MERS, COVID-19, as well as antimicrobial resistance. For more information, please visit https://www.ivi.int

About Dr. Jerome Kim

Jerome Kim, MD, is the Director General of the International Vaccine Institute (IVI) and an international expert on the evaluation and development of vaccines. His depth and breadth of scientific experience spans basic research through advanced clinical development. Dr. Kim was Principal Deputy and Chief of the Laboratory of Molecular Virology and Pathogenesis at the U.S. Military HIV Research Program. He led the Army’s Phase III HIV vaccine trial (RV144) which was the first demonstration that an HIV vaccine could protect against infection. He has authored over 250 publications and received the John Maher Award for Research Excellence from the Uniformed Services University of the Health Sciences in 2013.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200710005076/en/